Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target The firm noted that AbbVie sounded ...

AbbVie (ABBV) shares dip for 7th day, but analysts see buying opportunity after recent setback in schizophrenia drug trials.

The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

NORTH CHICAGO, Ill. - AbbVie Inc . (NYSE: NYSE:ABBV) disclosed today that its board of directors has declared a quarterly cash dividend. The payment, set at $1.55 per share, is... ByInvesting.com ...

Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...

More than 40,000 Gen Z and millennial Bumble users worldwide, including over 2,000 singles in India, participated in the survey.